麦角硫因被炮轰是“假药”，科伦药业回应

Core Viewpoint - The controversy surrounding the drug ergothioneine, labeled as a "fake drug" by a prominent biologist, has led to a response from Kelun Pharmaceutical, asserting the scientific validity of the product despite the criticism [1] Company Response - Kelun Pharmaceutical's staff stated that the company has never claimed ergothioneine to be a drug and believes the articles criticizing it have misrepresented the facts [1] - The company emphasizes that there is clear scientific research and clinical evidence supporting the efficacy of ergothioneine overseas [1] Market Reaction - Following the negative publicity, the company's stock experienced a significant decline, which the staff described as a normal market fluctuation and not directly linked to the controversy [1]